Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$0.21 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 9:59 PM 08/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Chiplin BPharm, Ph.D., MRPharm

Former Non-Executive Director, Progen Pharmaceuticals Limited
AgeTotal Calculated CompensationThis person is connected to 23 board members in 4 different organizations across 9 different industries.

See Board Relationships
56--

Background*

Dr. John Chiplin, BPharm, Ph.D., MRPharmS is the Founder and Managing Director of Newstar Ventures Ltd. Dr. Chiplin served as the Chief Executive Officer of Polynoma LLC since May 30, 2012. He served as a Founding Chief Executive Officer of Arana Therapeutics. He served as the Chief Executive Officer and Managing Director at Progen Pharmaceuticals Limited until April 2010. He served as an Interim Chief Executive Officer of Progen Pharmaceuticals Limited from December ...

Read Full Background

Corporate Headquarters*

2806 Ipswich Road
Darra, Queensland 4076

Australia

Phone: 61 7 3273 9133
Fax: 61 7 3375 1168

Board Members Memberships*

2010-Present
Non-Executive Director, Chairman of Remuneration & Nomination Committee and Member of Audit & Risk Committee
2010-Present
Director
2013-Present
Director and Chairman of Compensation Committee
2014-Present
Independent Non-Executive Director

Education*

PhD
Nottingham University
Bachelor's Degree
Nottingham University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGL:AU A$0.21 AUD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGEN PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.